Pfizer’s COVID-19 jab is the current record-holder for Big Pharma’s most profitable drug of all-time.
The experimental mRNA gene therapy made Pfizer $36.8 billion in 2021.
However, there is another prospective injection that may throttle that record if given the nod of approval by the corrupt FDA.
Tirzepatide, manufactured by Eli Lilly, is projected by some analysts to make upwards of $50 billion within its first year of sales.
Tirzepatide — sold under the brand name Mounjaro — is a weight-loss drug given as an injection.
If Eli Lilly’s weight-loss injection hits those projections, it would be the best-selling drug ever.
It is currently available off-label for weight loss patients, doctors say.
Big pharma's golden ticket: Sales of new weight-loss shot made by Eli Lilly forecast to hit $50BILLION this year – which would make it the best-selling drug of all time
via https://t.co/t7Lq79y5hK https://t.co/eCP7rMXHEs— Prof Imonokha Enakhena Jr (@IEnakhena) January 3, 2023
Daily Mail reported:
Analysts expect the drug — which is believed to be better than similar rival medications — to make anywhere from $25 to $48billion in the US in its first year.
That’s more than the current record holder, Pfizer’s Covid jab, which raked in $36.8billion in 2021, and more than double the $20.7 billion set by AbbVie’s rheumatoid arthritis drug Humira in the same year.
It comes after Wegovy – a similar fat-melting shot – was approved for obese children as young as 12.
Tirzepatide is already approved as a diabetes drug and is currently available off-label for weight-loss patients.
It is administered to patients as a weekly injection, which can be done at home.
The drug then works by binding to receptors for two appetite-regulating hormones — GLP-1 and GIP — sending signals to the brain that the body is full.
It also slows down the stomach’s ability to clear food, partly by reducing the amount of acid produced by the stomach, helping people feel fuller for longer.
It differs from Wegovy — made by the Danish company Novo Nordisk — because it mimics the effects of two hormones, whereas Wegovy only copies GLP-1.
Studies have indicated that tirzepatide is the most effective weight loss medication that has ever been available.
Yale University’s Dr Ania Jastreboff, who led clinical trials of the drug, heralded tirzepatide as ‘much more highly effective than any other medications we’ve had for the treatment of obesity’.
A phase three clinical trial involving 2,500 obese and overweight adults found tirzepatide slashed their bodyweight by a fifth in 72 months.
*Image from Daily Mail*
Instead of exercise, a nutritional diet, sunlight, herbs, adequate sleep, water intake, and other beneficial lifestyle changes, Big Pharma promotes an injection to stimulate weight loss.
Big Pharma relies on sick, unhealthy individuals to increase profits.
Because a healthy population means this wickedly corrupt industry goes out of business.
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!